T1	Outcomes 850 953	tumor response defined by â‰¥ 50% reduction in serum CA125 from baseline sustained for at least 28 days
T2	Outcomes 1134 1142	in CA125
T3	Outcomes 1275 1318	no symptomatic VTE or major bleeding events
T4	Outcomes 1353 1368	experienced VTE
T5	Outcomes 1451 1541	of D-dimer and thrombin-antithrombin, and higher levels of tissue factor pathway inhibitor
T6	Outcomes 1587 1594	is safe
T7	Outcomes 1599 1613	well tolerated
